(Q70023533)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949897%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

title

Natural cytotoxic activity in multiple sclerosis patients: defects in IL-2/interferon gamma-regulatory circuit (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949897%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

author name string

Braakman E

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949897%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

van Tunen A

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949897%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

Meager A

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949897%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

Lucas CJ

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949897%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

publication date

1 November 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949897%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

7 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949897%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949897%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949897%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

page(s)

285-294

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949897%20AND%20SRC:MED&resulttype=core&format=json

Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice

7 October 2019

cites work

1 reference

12 December 2020

Response of resting human peripheral blood natural killer cells to interleukin 2.

1 reference

12 December 2020

Interferon-gamma production by peripheral blood leucocytes from patients with multiple sclerosis and other neurological diseases

1 reference

12 December 2020

Ricin-resistant human T-cell hybridomas producing interferon gamma

1 reference

12 December 2020

Mechanisms in multiple sclerosis

1 reference

12 December 2020

Natural killer cell activity in multiple sclerosis and myasthenia gravis

1 reference

12 December 2020

IL-2- and IFN gamma-enhanced natural cytotoxic activity: analysis of the role of different lymphoid subsets and implications for activation routes

1 reference

12 December 2020

Virologic studies of multiple sclerosis and other chronic and relapsing neurological diseases

1 reference

12 December 2020

Spontaneous cell-mediated cytotoxicity in humans. Distribution and characterization of the effector cell

1 reference

12 December 2020

Natural killer cells: characteristics and regulation of activity

1 reference

12 December 2020

Absence of virus-induced lymphocyte suppression and interferon production in multiple sclerosis

1 reference

12 December 2020

Interferons and the immune system

1 reference

12 December 2020

Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor

1 reference

12 December 2020

Natural killing in systemic lupus erythematosus: inhibitory effects of serum

1 reference

12 December 2020

Cytotoxic activity and interferon production by lymphocytes from patients with multiple sclerosis

1 reference

12 December 2020

Interferon responses of leukocytes in multiple sclerosis

1 reference

12 December 2020

Natural killer cell activity in multiple sclerosis

1 reference

12 December 2020

Natural killing activity and interferon production in multiple sclerosis

1 reference

12 December 2020

Natural Killer Cell Activity in Patients with Multiple Sclerosis: Interferon and Plasmapheresis

1 reference

12 December 2020

Decreased NK killing in patients with multiple sclerosis: an analysis on the level of the single effector cell in peripheral blood and cerebrospinal fluid in relation to the activity in the disease

1 reference

12 December 2020

Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis

1 reference

12 December 2020

Natural killer cells in resistance to virus-infected cells

1 reference

12 December 2020

Normally occurring inhibitory cells for natural killer cell activity. II. Characterization of the inhibitory cell

1 reference

12 December 2020

Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes

1 reference

12 December 2020

Regulation of natural killer cell cytotoxicity by prostaglandin E in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. Part 1. Association between amount of prostaglandin produced, natu

1 reference

12 December 2020

Regulation of natural killer cell cytotoxicity by prostaglandin E in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. Part 2. Effect of exogenous PGE1 on spontaneous and interferon-ind

1 reference

12 December 2020

Interleukin 2 induces gamma-interferon production: participation of macrophages and NK-like cells

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells

1 reference

12 December 2020

Both Fc receptors and lymphocyte-function-associated antigen 1 on human T gamma lymphocytes are required for antibody-dependent cellular cytotoxicity (killer cell activity)

1 reference

12 December 2020

Augmentation of human natural cell-mediated cytotoxicity by recombinant human interleukin 2

1 reference

12 December 2020

Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects

1 reference

12 December 2020

In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells

1 reference

12 December 2020

Response to and production of interleukin 2 by peripheral blood and cerebrospinal fluid lymphocytes of patients with multiple sclerosis

1 reference

12 December 2020

Interferon production by cultured peripheral leucocytes of MS patients

1 reference

12 December 2020

Induction of cytolytic cells by pure recombinant human interleukin 2

1 reference

12 December 2020

Identifiers

1 reference